A group of investigators noted that Yap/TAZ expression in HCC was associated with high serum alpha-fetoprotein levels, increased proliferation activity, microvascular invasion, and stemness and epithelial-mesenchymal transition-related expression markers such as SMAD2/3, CAIX, and p53. This evidence concerns the gene YAP1 and hepatocellular carcinoma.